You just read:

Use Of Takeda's Entyvio Fueled By Gastroenterologists Seeking Better Outcomes And Alternatives To AbbVie's Humira And Janssen's Remicade In The Treatment Of Crohn's Disease

News provided by

Spherix Global Insights

Sep 23, 2016, 12:18 ET